Brief: Ventyx Biosciences Reports First Quarter 2023 Financial Results
May 11 (Reuters) - Ventyx Biosciences Inc VTYX.O :
* VENTYX BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT CORPORATE PROGRESS
* VENTYX BIOSCIENCES INC - CASH, CASH EQUIVALENTS &
MARKETABLE
SECURITIES OF $376.9 MILLION AS OF MARCH 31, EXPECTED TO FUND
PLANNED OPERATIONS INTO 2025
* VENTYX BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.68
Source text for Eikon: ID:nGNX28vjzJ
Further company coverage: VTYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ventyx Biosciences
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Deals of the day-Mergers and acquisitions